Hormone replacement therapy to ease menopause symptoms doesn’t increase a woman’s risk of brain tumors. Researchers found no link between hormone therapy and gliomas, the most common brain tumors in adults, according to results of a new study published recently in the journal Menopause. “Compared with nonusers, users of hormone therapy were not significantly associated with glioma risk,” a team led by senior researcher Dr. Hui Tang, a neurosurgeon with North Sichuan Medical College in Nanchong, China, wrote. No link was found even when researchers considered how long a woman had been taking hormone therapy, and whether she was currently using it. “Although there is a known sex difference in the incidence of gliomas, with women being six times more likely to develop the disease compared with men, there does not appear to be an association between glioma and hormone therapy use in postmenopausal women,” Dr. Stephanie Faubion, medical director for The Menopause Society, said in a news release. Hormone therapy is prescribed to treat common menopause symptoms like hot flashes, night sweats, mood swings and vaginal problems, researchers mentioned in background notes. The therapy had been widely used until 2002, when early clinical trial results showed an association between hormone therapy and increased risk of breast cancer, heart disease, stroke and blood clots. Since then, further study has shown that hormone therapy is indeed… read on > read on >

















